Latest News

Latest News

News from the World Hepatitis Alliance

WHA in official relations with WHO: What does this mean for you?

28 Feb 2015 Bridie Taylor

Fundamental to our ability to influence global hepatitis policy and bring about real change in the world of hepatitis is our relationship with the...

Assisting WHO in the development of a global strategy

31 Jan 2015 Bridie Taylor

World Health Organization Member States have urged WHO to develop a comprehensive global strategy on hepatitis. To assist in the development of this...

World Hepatitis Alliance’s ever-growing membership base

31 Jan 2015 Bridie Taylor

Central to the success of the World Hepatitis Alliance are our member groups around the world. To stimulate political interest in and action on...

Joining expert committees to promote harm reduction

31 Jan 2015 Bridie Taylor

Harm reduction policies are proven to save lives. Globally, as many as 67% of People Who Inject Drugs (PWIDs) have hepatitis C and an additional 8.4...

Promoting screening among high risk communities with new multi-lingual tool

31 Jan 2015 Bridie Taylor

In Europe, migrant populations are disproportionally affected by hepatitis B and C. Crucial to reducing the burden is improving screening among these...

Supporting the development of national action plans in South America

31 Jan 2015 Bridie Taylor

Government commitment to comprehensive national action plans is key to addressing the burden of viral hepatitis. To support the development of...

Exploring new treatment developments and innovative ways to finance healthcare

31 Jan 2015 Bridie Taylor

New therapeutic developments are revolutionising the way hepatitis is treated. But with a global lack of funding, how can these pioneering new drugs...

Pages

News from infohep

Hepatitis B raises the risk of some cancers

12 Aug 2019 Keith Alcorn
Chinese people with chronic hepatitis B infection had an increased risk of several digestive system cancers, especially stomach cancer, researchers...

Young adults with vertical HIV and hepatitis C co-infection have a high hepatitis C cure rate

8 Aug 2019 Liz Highleyman
Young adults with vertically transmitted HIV and hepatitis C virus (HCV) co-infection can easily be cured with direct-acting antivirals (DAAs),...

13% of HIV-positive Europeans who are cured of hepatitis C are reinfected

5 Aug 2019 Liz Highleyman
More than one in ten HIV-positive people in the large EuroSIDA cohort who were cured of hepatitis C were reinfected within two years, according to...

Hepatitis C does not raise risk of heart disease or cancers in people with HIV

18 Jul 2019 Keith Alcorn
Hepatitis C coinfection does not increase the risk of cardiovascular disease or non-AIDS cancers in people with HIV, an analysis of the large...

Hepatitis C treatment in primary care delivers higher cure rate for people who inject drugs

8 Jul 2019 Keith Alcorn
Providing treatment for hepatitis C in the primary care setting significantly improves the uptake of treatment and cure rates in people who inject...

Prescribers of opioid substitutes lack funding, facilities and guidelines to treat hepatitis C, global survey reveals

24 Jun 2019 Keith Alcorn
Only thirty percent of physicians who prescribe opioid substitution therapy to people who inject drugs have also prescribed direct-acting antivirals...

Risk of Parkinson's disease lower in people treated for hepatitis C

18 Jun 2019 Keith Alcorn
People with hepatitis C who received interferon-based treatment were less likely to develop Parkinson’s disease, a large study from Taiwan has...

Hepatitis C more stigmatising than HIV: gay men’s attitudes towards hepatitis C reinfection

13 Jun 2019 aidsmap.com
Qualitative research with HIV-positive gay and bisexual men in Australia who had been cured of hepatitis C infection revealed that having hepatitis C...

Just 18% of people with hepatitis/HIV co-infection and cirrhosis are screened for liver cancer as often as recommended

11 Jun 2019 Roger Pebody
There is a “strikingly low adherence” to clinical guidelines for ultrasound screening for hepatocellular carcinoma in Western Europe, researchers...

France switches to simplified pangenotypic hepatitis C treatment

5 Jun 2019 Keith Alcorn
French health authorities have recommended that everyone diagnosed with hepatitis C should be treated with a pangenotypic direct-acting antiviral...